N-Acetylcysteine (NAC) for longevity

At a Glance

Mechanism of Action

Deacetylated to cysteine, the rate-limiting amino acid for glutathione synthesis. Also modulates glutamate signalling in the nucleus accumbens, which is the likely basis for its effects on compulsive behaviour.

N-Acetylcysteine (NAC) is typically taken orally as capsule; regulatory status as a supplement has been contested in the us but not in the uk, away from food for absorption; split if above 1.2 g. Deacetylated to cysteine, the rate-limiting amino acid for glutathione synthesis. Also modulates glutamate signalling in the nucleus accumbens, which is the likely basis for its effects on compulsive behaviour. Effective range is 600 mg - 2.4 g, with 600-1,200 mg daily being the most-studied dose. It does not require food, and fasted dosing is often preferred for absorption or timing reasons.

Dosage & Timing

Splitting the daily dose keeps plasma concentrations steadier, which matters for compounds with a shorter half-life or narrower therapeutic window.

How to Take

1. Start at the lower end of the range (600 mg - 2.4 g) for the first 7–10 days to gauge tolerance.
2. Titrate up to the target dose of 600-1,200 mg daily once tolerance is confirmed.
3. Fasted or with a light snack is acceptable — food is not required.
4. Best timing: Away from food for absorption; split if above 1.2 g. Keep the daily window consistent so effects are legible against baseline.
5. Missed dose: skip and resume normally; never double up.

Absorption & Bioavailability

• Absorption for N-Acetylcysteine (NAC) is generally reliable at 600-1,200 mg daily; splitting the daily dose into two smaller servings can smooth plasma concentrations.
• Hydrate adequately — most oral supplements are absorbed better when total daily water intake is above 30 ml/kg.

Cycling & Stacking Strategy

• Most users run N-Acetylcysteine (NAC) continuously and reassess every 12 weeks with bloods and a symptom log.
• If effect plateaus, a 2–4 week wash-out often restores responsiveness by resetting receptor sensitivity and feedback loops.
• Common stack: Glycine, Vitamin C, Selenium. Introduce one addition at a time so you can attribute effect and side effect.
• Rotate related supplements seasonally rather than layering five products in the same category.

Who This Is For

What to Monitor

Reported Benefits

• Restores glutathione, the antioxidant that falls most reliably with age
• Established clinical use as a mucolytic and as the antidote in paracetamol overdose
• Reduced symptoms in trichotillomania and related compulsive disorders in randomised trials
• Part of the GlyNAC combination that improved multiple ageing markers in older adults

Safety Profile

How to Choose a Quality Product

• Third-party tested — look for NSF, Informed Sport, USP or an equivalent independent COA (certificate of analysis) on the batch you're buying.
• Standardised active — the label should specify the exact active compound and its concentration, not just the botanical name.
• Minimal excipients — avoid unnecessary fillers, artificial colours and shared allergens (soy, gluten) unless you're happy to test for reactions.
• Dose per serving matches the researched range (600 mg - 2.4 g) — many consumer products under-dose to widen margins.
• Manufactured in a cGMP-certified facility with a clear country of origin.
• Reasonable price per effective dose — cheaper products often deliver less active per capsule, so the true cost-per-dose is higher.

Common Mistakes

• Under-dosing — using 600 mg - 2.4 g when the research uses 600-1,200 mg daily.
• Stopping after two weeks — most longevity-relevant endpoints need 8–12 weeks of consistent dosing before they move on bloods.
• No baseline labs, so any effect is attributed to placebo or hype rather than to the supplement.
• Stacking three or four new products in the same month — you lose all ability to attribute results.
• Buying the cheapest brand and skipping the third-party COA — potency and purity vary dramatically between manufacturers.
• Timing it inconsistently — the biological effect depends on steady exposure, not sporadic doses.

Evidence Grade — B (64/100)

Grade B — mechanism is credible and at least one human trial, pharmacokinetic study or strong observational evidence exists. Long-term effects on healthspan endpoints are still incomplete.

The primary references used to grade N-Acetylcysteine (NAC) are listed below. Cross-check against the current literature and expect the grade to move as new human trials publish.

References

1. [1]Supplementing glycine and N-acetylcysteine (GlyNAC) in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function and aging hallmarks: a randomized clinical trial — Journals of Gerontology: Series A, 2023
2. [2]N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action — Journal of Psychiatry & Neuroscience, 2011

Further reading: Research library → · Protocols →